121 related articles for article (PubMed ID: 22665592)
1. A 29-year-old renal transplant recipient with acute respiratory failure.
Arango C; Arango C; Seas C
Am J Trop Med Hyg; 2012 Jun; 86(6):911-912. PubMed ID: 22665592
[No Abstract] [Full Text] [Related]
2. Strongyloides stercoralis hyperinfection presenting as acute respiratory failure and Gram-negative sepsis in a patient with astrocytoma.
Shorman M; Al-Tawfiq JA
Int J Infect Dis; 2009 Sep; 13(5):e288-91. PubMed ID: 19231269
[TBL] [Abstract][Full Text] [Related]
3. A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review.
Qu TT; Yang Q; Yu MH; Wang J
Medicine (Baltimore); 2016 May; 95(19):e3638. PubMed ID: 27175679
[TBL] [Abstract][Full Text] [Related]
4. Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome.
El-Sameed YA; Beejay N; Al Maashari R
Clin Respir J; 2015 Oct; 9(4):489-92. PubMed ID: 24902477
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
Huston JM; Eachempati SR; Rodney JR; Cayci C; Fusco D; Mathew M; Shou J; Goldstein MJ; Kapur S; Barie PS
Transpl Infect Dis; 2009 Jun; 11(3):277-80. PubMed ID: 19392733
[TBL] [Abstract][Full Text] [Related]
6. Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature.
Donadello K; Cristallini S; Taccone FS; Lorent S; Vincent JL; de Backer D; Jacobs F
Int J Antimicrob Agents; 2013 Dec; 42(6):580-3. PubMed ID: 24269075
[TBL] [Abstract][Full Text] [Related]
7. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Peters L; McCarthy AE; Faught C
Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
[TBL] [Abstract][Full Text] [Related]
8. Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient.
Briasoulis A; Psevdos G
South Med J; 2011 Jan; 104(1):72-3. PubMed ID: 21119560
[No Abstract] [Full Text] [Related]
9. Images in clinical medicine. Strongyloides stercoralis hyperinfection.
Gorman SR; Craven DE
N Engl J Med; 2008 Sep; 359(11):e12. PubMed ID: 18784094
[No Abstract] [Full Text] [Related]
10. Donor-derived strongyloidiasis after organ transplantation in Norway.
Nordheim E; Olafsson Storrø M; Natvik AK; Birkeland Kro G; Midtvedt K; Varberg Reisaeter A; Hagness M; Fevang B; Pettersen FO
Transpl Infect Dis; 2019 Feb; 21(1):e13008. PubMed ID: 30295406
[TBL] [Abstract][Full Text] [Related]
11. [Strongyloides stercoralis hyperinfection syndrome in a Colombian patient receiving immunosuppressive treatment].
Rojo-Marcos G; Cuadros-González J; González-Juárez MJ; Gómez-Ayerbe C
Enferm Infecc Microbiol Clin; 2009; 27(7):432-4. PubMed ID: 19477050
[No Abstract] [Full Text] [Related]
12. [Respiratory and renal insufficiency in a COPD patient receiving corticoid treatment].
Tirado MD; Gil M; Galiano J; Pardo F; Moreno R; Del Busto AG; Sabater S; Gomila B
Enferm Infecc Microbiol Clin; 2002 Oct; 20(8):401-2. PubMed ID: 12372237
[No Abstract] [Full Text] [Related]
13. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.
Hauber HP; Galle J; Chiodini PL; Rupp J; Birke R; Vollmer E; Zabel P; Lange C
Infection; 2005 Oct; 33(5-6):383-6. PubMed ID: 16258873
[TBL] [Abstract][Full Text] [Related]
14. Strongyloides stercoralis Hyperinfection and Intractable Pulmonary Hemorrhage.
Sankar J; Gupta S; Lingaiah R
J Pediatr; 2020 Mar; 218():258. PubMed ID: 31740146
[No Abstract] [Full Text] [Related]
15. [A LOCAL CASE OF CHRONIC STRONGYLOIDIASIS IN THE VOLGOGRAD REGION].
Boruk TF; Plyushcheva GL; Zelya OP
Med Parazitol (Mosk); 2015; (4):39-40. PubMed ID: 26827587
[TBL] [Abstract][Full Text] [Related]
16. Decrease in eosinophilia as a marker of response to therapy in solid organ transplant candidates with Strongyloides infection: A single-center experience.
Simkins J; Anjan S; Camargo JF
Transpl Infect Dis; 2018 Oct; 20(5):e12954. PubMed ID: 29896920
[No Abstract] [Full Text] [Related]
17. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.
Leung V; Al-Rawahi GN; Grant J; Fleckenstein L; Bowie W
Am J Trop Med Hyg; 2008 Dec; 79(6):853-5. PubMed ID: 19052292
[TBL] [Abstract][Full Text] [Related]
18. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
19. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
[TBL] [Abstract][Full Text] [Related]
20. Fatal cutaneous Strongyloidiasis as a side effect of Pemphigus foliaceus treatment with mycophenolate mofetil.
Vitiello M; Shelling M; Camacho I; Milikowski C; Kerdel FA
J Drugs Dermatol; 2011 Apr; 10(4):418-21. PubMed ID: 21455554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
